Literature DB >> 8475182

Time-gated fluorescence imaging for the diagnosis of tumors in a murine model.

R Cubeddu1, G Canti, P Taroni, G Valentini.   

Abstract

A system for time-gated fluorescence imaging was used to perform measurements on tumor-bearing mice treated with hematoporphyrin derivative (HpD). The aim of the study was to define the potential of this technique in the diagnosis of tumors by taking advantage of the long fluorescence lifetime of the exogenous dye with respect to the decay times of the natural fluorescence. After the administration of three different drug doses (5, 10 and 25 mg/kg body weight), fluorescence images were acquired at various uptake times (from 2 h to 10 d), to determine the best instrumental conditions and experimental procedure for the detection of tumors in the murine model considered. The optimal fluorescence contrast between the tumor area and the surrounding healthy tissue was found at 12 h after the administration of either 5 or 10 mg/kg HpD and was anticipated at 8 h for the highest drug dose. In this optimum condition, the tumor region could be identified even after the injection of 5 mg/kg HpD. A better fluorescence contrast was always obtained in 15 ns-delayed images with respect to synchronous ones.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8475182     DOI: 10.1111/j.1751-1097.1993.tb02322.x

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  9 in total

Review 1.  Fluorescence lifetime measurements and biological imaging.

Authors:  Mikhail Y Berezin; Samuel Achilefu
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

2.  Imaging a photodynamic therapy photosensitizer in vivo with a time-gated fluorescence tomography system.

Authors:  Weirong Mo; Daniel Rohrbach; Ulas Sunar
Journal:  J Biomed Opt       Date:  2012-07       Impact factor: 3.170

3.  Hyperspectral imaging and spectral unmixing for improving whole-body fluorescence cryo-imaging.

Authors:  Dennis Wirth; Brook Byrd; Boyu Meng; Rendall R Strawbridge; Kimberley S Samkoe; Scott C Davis
Journal:  Biomed Opt Express       Date:  2020-12-16       Impact factor: 3.732

4.  Gated Luminescence Imaging of Silicon Nanoparticles.

Authors:  Jinmyoung Joo; Xiangyou Liu; Venkata Ramana Kotamraju; Erkki Ruoslahti; Yoonkey Nam; Michael J Sailor
Journal:  ACS Nano       Date:  2015-06-09       Impact factor: 15.881

5.  A multimode optical imaging system for preclinical applications in vivo: technology development, multiscale imaging, and chemotherapy assessment.

Authors:  Jae Youn Hwang; Sebastian Wachsmann-Hogiu; V Krishnan Ramanujan; Julia Ljubimova; Zeev Gross; Harry B Gray; Lali K Medina-Kauwe; Daniel L Farkas
Journal:  Mol Imaging Biol       Date:  2012-08       Impact factor: 3.488

6.  Tumour visualization in a murine model by time-delayed fluorescence of sulphonated aluminium phthalocyanine.

Authors:  R Cubeddu; G Canti; P Taroni; G Valentini
Journal:  Lasers Med Sci       Date:  1997-10       Impact factor: 3.161

7.  Multimode Optical Imaging for Translational Chemotherapy: In Vivo Tumor Detection and Delineation by Targeted Gallium Corroles.

Authors:  Jae Youn Hwang; Zeev Gross; Harry B Gray; Lali K Medina-Kauwe; Daniel L Farkas
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2011-02-28

8.  Predicting in vivo fluorescence lifetime behavior of near-infrared fluorescent contrast agents using in vitro measurements.

Authors:  Walter J Akers; Mikhail Y Berezin; Hyeran Lee; Samuel Achilefu
Journal:  J Biomed Opt       Date:  2008 Sep-Oct       Impact factor: 3.170

9.  In vivo time-gated fluorescence imaging with biodegradable luminescent porous silicon nanoparticles.

Authors:  Luo Gu; David J Hall; Zhengtao Qin; Emily Anglin; Jinmyoung Joo; David J Mooney; Stephen B Howell; Michael J Sailor
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.